Shepherd Kaplan Krochuk’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-49,421	Closed	-$143K	–	278
2017 Q3	$143K	Hold	49,421	–	–	0.12%	166
2017 Q2	$220K	Hold	49,421	–	–	0.13%	158
2017 Q1	$230K	Sell	49,421 -21,109	-30%	-$122K	0.12%	150
2016 Q4	$430K	Sell	70,530 -64,535	-48%	-$337K	0.12%	97
2016 Q3	$744K	Hold	135,065	–	–	0.15%	81
2016 Q2	$513K	Buy	135,065 +19,395	+17%	+$65.7K	0.13%	107
2016 Q1	$319K	Buy	+115,670	New	+$419K	0.1%	156
2015 Q4	–	Sell	-113,276	Closed	-$600K	–	458
2015 Q3	$600K	Hold	113,276	–	–	0.16%	96
2015 Q2	$940K	Hold	113,276	–	–	0.18%	95
2015 Q1	$523K	Buy	113,276 +44,166	+64%	+$144K	0.09%	170
2014 Q4	$211K	Buy	+69,110	New	+$204K	0.03%	335

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Shepherd Kaplan Krochuk's SGYP Position: Q4 2017 in Review

Shepherd Kaplan Krochuk sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 49,421 shares — an estimated $143K sold.

Shepherd Kaplan Krochuk first reported a position in SGYP in Q4 2014 and held it in 11 quarters. The position peaked at $940K in Q2 2015. 150 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

Shepherd Kaplan Krochuk reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 49,421 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $143K.
Shepherd Kaplan Krochuk first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2014 and held it in 11 quarters.
Shepherd Kaplan Krochuk's Synergy Pharmaceuticals, Inc Common Stock position peaked at $940K in Q2 2015.
150 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2017, filed 13 Feb 2018.